Jul 27, 2026 04:04PM MapLight Therapeutics (MPLT) PT Lowered to $30 at Wolfe Research

Jul 27, 2026 02:29PM Raymond James on Bristol-Myers Squibb Co. (BMY): 'we do not view the ZEPHYR data as signaling a risk to Cobenfy across indications'

Jul 27, 2026 09:49AM TD Cowen on MapLight Therapeutics (MPLT): 'tolerability looked favorable'

Jul 27, 2026 09:10AM MapLight Therapeutics (MPLT) PT Lowered to $35 at Raymond James

Jul 27, 2026 09:09AM Jefferies on MapLight Therapeutics (MPLT): 'there are still several positives to consider'

Jul 27, 2026 08:15AM BMO Capital on MapLight Therapeutics (MPLT): 'we contest that opportunity remains in schizophrenia with more upside from Alzheimer's psychosis'

Jul 27, 2026 07:23AM Stifel on MapLight Therapeutics (MPLT): 'The last point will likely be the pushback on the data'

Jul 24, 2026 07:52AM MapLight Therapeutics (MPLT) PT Raised to $43 at Canaccord

Jul 21, 2026 08:42AM MapLight Therapeutics (MPLT) PT Raised to $52 at UBS on Enhanced Sales Outlook

Jul 20, 2026 04:08PM BMO Capital Starts MapLight Therapeutics (MPLT) at Outperform

Jul 10, 2026 07:05AM MapLight Therapeutics (MPLT) PT Raised to $45 at Needham

Jun 24, 2026 04:25PM Raymond James Starts MapLight Therapeutics (MPLT) at Strong Buy

Jun 23, 2026 06:49AM H.C. Wainwright Reiterates Buy Rating on MapLight Therapeutics (MPLT)

Jun 22, 2026 07:04AM H.C. Wainwright Reiterates Buy Rating on MapLight Therapeutics (MPLT)

Jun 1, 2026 04:13PM MapLight Therapeutics (MPLT) PT Raised to $36 at Stifel

May 26, 2026 04:15PM UBS Starts MapLight Therapeutics (MPLT) at Buy

May 21, 2026 10:10AM Craig-Hallum Starts MapLight Therapeutics (MPLT) at Buy

May 15, 2026 06:03AM MapLight Therapeutics, Inc. (MPLT) Misses Q1 EPS by 42c

Apr 8, 2026 05:21AM Needham Starts MapLight Therapeutics (MPLT) at Buy

Apr 7, 2026 05:29AM TD Cowen Starts MapLight Therapeutics (MPLT) at Buy

Mar 26, 2026 12:15PM Stifel stays Buy rated on MapLight Therapeutics (MPLT) after in-line Q4 update

Mar 19, 2026 05:12AM Canaccord Starts MapLight Therapeutics (MPLT) at Buy

Jan 5, 2026 07:03AM MapLight Therapeutics gets FDA fast track status for Alzheimer's drug

Dec 3, 2025 10:44AM Jefferies on MapLight Therapeutics (MPLT): 'Cleaner Catalyst Flow as Competitor Pushes Back Alz Psychosis Data to YE:26'

Nov 21, 2025 06:20AM Leerink Partners Starts MapLight Therapeutics (MPLT) at Outperform

Nov 21, 2025 01:07AM Jefferies Starts MapLight Therapeutics (MPLT) at Buy

Nov 21, 2025 01:06AM Stifel Starts MapLight Therapeutics (MPLT) at Buy

Nov 21, 2025 12:57AM Morgan Stanley Starts MapLight Therapeutics (MPLT) at Overweight

Oct 23, 2025 11:52AM MapLight (MPLT) reportedly to stop taking IPO orders at noon Thursday

Oct 20, 2025 10:53AM MapLight Therapeutics IPO reportedly well oversubscribed

Oct 6, 2025 04:11PM MapLight Therapeutics files for 14.75M share IPO at $17/sh

Sep 19, 2025 04:15PM MapLight (MPLT) files for proposed Nasdaq IPO